comparemela.com

Prosciento Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CymaBay Therapeutics, Inc (NASDAQ:CBAY) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Third Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

ProScientos Appoints Dr Michelle Mazuranic as Vice President of Medical and Regulatory Affairs

ProSciento, Inc., a specialty clinical research organization (CRO) focused exclusively on diabetes, obesity, non-alcoholic steatohepatitis (NASH), and related metabolic diseases, has announced the appointment of Michelle Mazuranic, PhD, MSM, RD, as Vice President of Medical and Regulatory Affairs .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.